Bryan T Oronsky

This inventor holds 29 USPTO granted patents and 27 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Cancer Treatment. Top assignees: Epicentrx, Inc., Comgenrx, Inc., Alliant Techsystems Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryan T Oronsky. Retrieved from https://idiyas.com/inventor/bryan-t-oronsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 27)

% Patents Active = 96.6

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 18)

Average Co-Inventor Count = 2.5

ph-index = 9

Forward Citations = 159(Granted Patents)

Location History:

La Jolla, CA (US) (2022)
Los Altos Hills, CA (US) (2012 - 2024)

Company Filing History:

Alliant Techsystems Inc.

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Personalized Cancer Vaccines

Adenoviruses

Immunomodulatory Proteins

Combination Therapy

Organonitro Compounds

Radioprotection

Medication Infusion Devices

Transgene Delivery

Therapeutic Agents

Gliomas

Brain Metastases

Thioether Compounds

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12357608 - Methods and compositions utilizing RRx-001 combination therapy for radioprotection (2025-07-15),

2. 12357607 - Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (2025-07-15),

3. 12295976 - Personalized cancer vaccines (2025-05-13),

4. 12291726 - A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter (2025-05-06),

5. 12280123 - Recombinant adenoviruses carrying transgenes (2025-04-21),

6. 12109348 - Medication infusion devices, systems, and methods (2024-10-08),

7. 12054530 - Immunomodulatory fusion proteins (2024-08-06),

8. 12048793 - Medication infusion devices, systems, and methods (2024-07-30),

9. 12036247 - Multiple transgene recombinant adenovirus (2024-07-16),

10. 11999973 - Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter (2024-06-04),

11. 11834492 - Human IL-10 receptor alpha fusion proteins (2023-12-05),

12. 11744859 - Compositions and methods for parenteral administration of therapeutic agents (2023-09-05),

13. 11701351 - Treatment of gliomas using organonitro compound combination therapy (2023-07-18),

14. 11660286 - Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products (2023-05-30),

15. 11576895 - Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (2023-02-14),

Title: The Innovative Contributions of Bryan T. Oronsky

Introduction

Bryan T. Oronsky, a prominent inventor based in La Jolla, California, has made significant strides in the fields of biotechnology and medical devices. With an impressive portfolio of 25 patents, Oronsky's work primarily revolves around the development of recombinant adenoviruses and advanced medication infusion systems, showcasing his dedication to innovation in healthcare.

Latest Patents

Oronsky's latest patents illustrate his pioneering contributions to medical science. One of these patents involves "Recombinant adenoviruses carrying transgenes," which details the use of recombinant adenoviruses with nucleotide sequences inserted between viral transcription units. This innovation not only brings forth methods of treatment using these recombinant adenoviruses but also outlines specific insertion sites to enhance their effectiveness.

Another notable patent is for "Medication infusion devices, systems, and methods," which describes novel devices and systems for medication infusion. The system encompasses a patient access subassembly, multiple fluid reservoirs, and a versatile assembly that can be configured in various ways to ensure efficient medication delivery.

Career Highlights

Throughout his career, Bryan Oronsky has worked with influential companies that have bolstered his innovative efforts. He has been associated with Epicentrx, Inc. and Comgenrx, Inc., where he collaborated on various projects that pushed the boundaries of existing medical technologies.

Collaborations

Oronsky's work has also involved notable collaborations with industry experts such as Jan Scicinski and Tony R. Reid. These partnerships have played a crucial role in enhancing the development of his patented inventions, leveraging collective expertise to drive innovative solutions in the medical field.

Conclusion

Bryan T. Oronsky's contributions to the realms of biotechnology and medical devices exemplify his commitment to improving patient care through innovative inventions. With a strong portfolio of patents and a collaborative spirit, Oronsky continues to push forward the frontiers of medical technology, positioning himself as a key figure in the ongoing evolution of healthcare solutions.

Profile summary based on public USPTO records.